Evidence map›Paper›PMID 33577601›Full record

ArticlePLoS neglected tropical diseases2021

Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: Repeated cross-sectional studies.

Lydia Trippler, Shaali Makame Ame, Jan Hattendorf, Saleh Juma, Salum Abubakar, Said Mohammed Ali, Fatma Kabole, David Rollinson, Stefanie Knopp

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Tropical medicine and infectious disease · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. School-Based Epidemiology ofInfection and drug resistance · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Inhibiting Liver Autophagy and Promoting Hepatocyte Apoptosis byTropical medicine and infectious disease · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Lydia TripplerSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID 0000-0003-2342-0844
Shaali Makame AmePublic Health Laboratory-Ivo de Carneri, Pemba, United Republic of Tanzania.
Jan HattendorfSwiss Tropical and Public Health Institute, Basel, Switzerland.
Saleh JumaNeglected Diseases Program, Ministry of Health, Zanzibar, United Republic of Tanzania.
Salum AbubakarNeglected Diseases Program, Ministry of Health, Zanzibar, United Republic of Tanzania.ORCID 0000-0003-1804-096X
Said Mohammed AliPublic Health Laboratory-Ivo de Carneri, Pemba, United Republic of Tanzania.
Fatma KaboleNeglected Diseases Program, Ministry of Health, Zanzibar, United Republic of Tanzania.
David RollinsonDepartment of Life Sciences, Natural History Museum, London, United Kingdom.ORCID 0000-0003-1999-1716
Stefanie KnoppSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID 0000-0001-5707-7963
Swiss Tropical and Public Health Institute · CHZanzibar University · TZPublic Health Laboratory Ivo de Carneri · TZNatural History Museum · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsiderable progress towards the elimination of urogenital schistosomiasis was made by the Zanzibar Elimination of Schistosomiasis Transmission project from 2012 till 2016, when biannual praziquantel mass drug administration (MDA) alone or with additional snail control or behaviour change interventions were implemented. Annual MDA was continued in 2017 and 2018, but not in 2019, imposing a 16-month treatment gap. We monitored the Schistosoma haematobium prevalence from 2012 till 2020 and assessed recrudescence patterns with focus on 2020. METHODOLOGY: Repeated cross-sectional surveys were conducted from 2011/12 till 2020 in 90 communities and 90 schools in Zanzibar. Annually, around 4,500 adults and up to 20,000 schoolchildren were surveyed. The S. haematobium prevalence was detected by urine filtration and reagent strips. In 2020, risk factors for infection were investigated using generalized estimated equation models. PRINCIPAL

findingsIn adults, the apparent S. haematobium prevalence was 3.9% in 2011 and 0.4% in 2020. In schoolchildren, the prevalence decreased from 6.6% in 2012 to 1.2% in 2019 with vicissitudes over the years. Prominent recrudescence of infection from 2.8% in 2019 to 9.1% (+225%) in 2020 was observed in 29 schools with historically moderate prevalences (≥10%). Compared with 2019, reinfection in 2020 was particularly striking in boys aged 9-16 years. Being male was a risk factor for infection in 2020 (adults: odds ratio (OR): 6.24, 95% confidence interval (95% CI): 1.96-19.60; schoolchildren: OR: 2.06, 95% CI: 1.52-2.78). Living near to a natural freshwater body significantly increased the odds of infection in adults (OR: 2.90, CI: 1.12-7.54). CONCLUSIONS/SIGNIFICANCE: After 11 rounds of MDA over 7 years and a 16-month treatment gap, the urogenital schistosomiasis prevalence considerably rebounded in hotspot areas. Future elimination efforts in Zanzibar should focus on re-intensifying MDA plus additional interventions in hotspot areas. In low-prevalence areas, the strategy might be adapted from MDA to targeted surveillance-response.

Indexed as

AdolescentAdultAnimalsChildCross-Sectional StudiesFemaleHumansMaleMass Drug AdministrationMiddle AgedPraziquantelPrevalenceRecurrenceRisk FactorsSchistosoma haematobiumSchistosomiasis haematobiaPraziquantel

Identifiers

PMID33577601
PMCPMC7880478
OpenAlexW3128576432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.